August 4, 2025

A Probiotic Containing L. Plantarum and P. Acidilactici Strains for Treating Upper Respiratory Infection in Children Aged 6 Months to 5 Years: A Randomized, Double-Blind Trial

View Full Paper

Ask AI

Bookmark

Intervention with L. plantarum and P. acidilactici reduced duration of fever by 1.1 days in children with upper respiratory infections.
Participants experienced a 0.7-day reduction in pain/discomfort compared to the placebo group, showing promising results.
Seventy-five children aged 6 months to 5 years were randomized into probiotic and placebo groups for the trial.
No significant differences in adverse events or comedication use were observed between the probiotic and placebo groups.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Randomized trial shows reduced duration of fever and pain in children with upper respiratory infection, implying probiotics can be effective against viral origins.

Cite This Study

Andrade‐Platas et al. (2025) studied this question.

synapsesocial.com/papers/689a0f86e6551bb0af8d09da https://doi.org/10.21203/rs.3.rs-7214019/v1

View Full Paper

Ask AI

Bookmark

Implication

Randomized trial shows reduced duration of fever and pain in children with upper respiratory infection, implying probiotics can be effective against viral origins.

A Probiotic Containing L. Plantarum and P. Acidilactici Strains for Treating Upper Respiratory Infection in Children Aged 6 Months to 5 Years: A Randomized, Double-Blind Trial

Key Points

Discussion

Implication

Cite This Study

A Probiotic Containing L. Plantarum and P. Acidilactici Strains for Treating Upper Respiratory Infection in Children Aged 6 Months to 5 Years: A Randomized, Double-Blind Trial

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider